Analystreport

Caladrius Biosciences Inc (NASDAQ: CLBS) is now covered by analysts at WBB Securities. They set a "buy" rating and a $6.75 price target on the stock.

Caladrius Biosciences, Inc.  (CLBS) 
Last caladrius biosciences, inc. earnings: 11/6 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: caladrius.com/investors/overview